
Targeted alpha therapy of NETs using somatostatin-based radiopharmaceuticals with improved tumor-to-kidney ratio, the theranostic approach.
Prof. Dr. Apr. Frederik Cleeren
Prof. Dr. Apr. Frederik Cleeren
Minah Kim, PhD
Po Hien Ear, PhD
Christopher Heaphy, PhD
Kwok-Kin Wong, MD, PhD
Guillermina Lozano, PhD
Guillermina Lozano, PhD
Laura Banaszynski, PhD
Steven K Libutti, MD
Wolfgang Weber, MD, PhD; Diane Reidy-Lagunes, MD